BioFLO for Respiratory Recovery in SCI
Genetic Biomarkers of Intermittent Hypoxia-Induced Respiratory Motor Plasticity in Chronic SCI
2 other identifiers
interventional
62
1 country
1
Brief Summary
Acute intermittent hypoxia (AIH) involves brief (1 min), repeated episodes (\~15) of breathing low oxygen air to stimulate spinal neuroplasticity. Animal and human studies show that AIH improves motor function after spinal cord injury, particularly with slightly increased carbon dioxide (hypercapnic AIH; AIHH) and task-specific training. Using a double blind cross-over design, the study will test whether AIHH improves breathing more than AIH and whether specific genetic variations are related to individuals' intervention responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2023
CompletedFirst Posted
Study publicly available on registry
August 25, 2023
CompletedStudy Start
First participant enrolled
December 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
November 5, 2025
November 1, 2025
3.5 years
August 1, 2023
November 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in motor evoked potential
The change in peak-to-peak amplitude of the motor evoked potential of the diaphragm will be tested using transcranial magnetic stimulation.
Baseline, and 45-60 minutes after intervention on AIH day, AIHH day, and Sham AIH day
Change in maximal inspiratory pressure
Maximal inspiratory pressure is a non-invasive measure of the maximal force achieved when breathing in against an occluded airway.
Baseline, 1 day, 3 days, and 7 days after intervention blocks (daily AIH + respiratory strength training, daily AIHH + respiratory strength training, daily sham AIH + respiratory strength training.)
Change in maximal expiratory pressure
Maximal expiratory pressure is a non-invasive measure of the maximal force achieved when breathing out against an occluded airway.
Baseline, 1 day, 3 days, and 7 days after intervention blocks (daily AIH + respiratory strength training, daily AIHH + respiratory strength training, daily sham AIH + respiratory strength training.)
Study Arms (2)
Single-session testing days
EXPERIMENTALParticipants will complete three separate single-session testing days. Baseline testing will be performed, then on each day, participants will receive AIH, AIHH, and sham AIH in random order. Post-testing will occur after each intervention.
Respiratory strength training blocks
EXPERIMENTALParticipants will complete three separate respiratory strength training blocks. In each block, participants will receive 5 days of AIH, 5 days of AIHH, and 5 days of sham AIH in random order, followed by respiratory strength training. Each block will include 5 days of intervention and training, and post-testing 1, 3, and 7 days after intervention and training has concluded.
Interventions
AIH (acute intermittent hypoxia) consists of short episodes of low oxygen (9% O2).
AIHH consists of short episodes of low oxygen (9% O2) and elevated carbon dioxide (4% CO2).
A single session of sham AIH with episodes of normal room air (21% O2).
Eligibility Criteria
You may qualify if:
- Adults 18-70 years of age
- Chronic incomplete SCI ≥ 1 year at or below C1-T12
- Incomplete SCI based on residual sensory and motor function below the level of the injury or injury classification of B, C, D at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI.
- OR- Chronic complete SCI ≥1 year at or below C4-T12
- Complete SCI based on the absence of residual sensory or motor function below the level of injury or injury classification of A at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI.
- Medically stable with physician clearance
- SCI due to non-progressive etiology
- % impairment in maximal inspiratory, maximal expiratory pressure generation, or both relative to normative values
You may not qualify if:
- Current diagnosis of an additional neurologic condition such as Multiple Sclerosis, Parkinson disease, stroke, or brain injury
- Severe illness or infection, including non-healing decubitus ulcers, untreated bladder or urinary tract infections, cardiovascular disease, lung disease, active heterotopic ossification, or uncontrolled hypertension
- Severe neuropathic pain
- Known pregnancy
- Severe recurrent autonomic dysreflexia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brooks Rehabilitation
Jacksonville, Florida, 32216, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emily Fox, DPT, MHS, PhD
University of Florida & Brooks Rehabilitation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2023
First Posted
August 25, 2023
Study Start
December 21, 2023
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
November 5, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share